Search PubMed⌕ Search

Biomedical subjects

A Mayr

Publications and source records attributed to A Mayr.

At least 163 records · Page 9Linked to original sources

[Facts and speculations on viruses in food (author's transl)].

The danger to which man is exposed as a result of viruses contained in food differs basically from the risk to man caused by bacteria, fungi or their toxins. With respect to viral injuries it is not the specific diseases (e.g. hepatitis and polio) that are in the foreground but the much more dangerous noxious groups whose cause/effect relationships are rather complex. 1. the oncogenic risk, 2. synergistic interactions with opportunistic problem viruses, 3. slowly developing chronic diseases and persistent infections with their indirect injuries, 4. new infectious pathogens (viroids). Viral contamination of food can be exogenous or endogenous. Exogenous contamination is possible by: 1. specific human-pathogenic viruses, 2. polyphagous, human-pathogenic and animal-pathogenic viruses (zoonosis), 3. animal-pathogenic viruses only, 4. fish viruses, 6. bacteriophages, 7. fungal viruses. The viruses of group 1 and 2 are of practical importance, those of group 6 and 7 are it occasionally. Endogenous contamination is caused when an animal suffered from a viral infection at the time of slaughter or product extraction (e.g. milk, egg, fish) or when the animal has picked up a virus shortly beforhand. As far as endogenous contamination is concerned, a distinction must be made between 1. primarily biological and 2. primarily mechanical contamination. For the first, mainly the clinically inapparent especially persistent infections and viraemic stages at the end of incubation are dangerous. In both cases the animal is clinically healthy. In primarily biological contamination the zoonosis viruses predominate. In addition the bacteriophages must be taken into account. Primarily mechanical contamination is restricted to fish, molluscs, milk and eggs. The possibilities and consequences of exogenous and endogenous contamination are discussed. The risk of viral transmission by foodstuffs depends chiefly on the tenacity of the virus in the affected food, but also on its virulence and concentration. Basic considerations are discussed. Practically from any useful, healthy animal the most varied viruses can be isolated. In order to avoid destroying the confidence of the consumer, it is necessary to take stock of the following: 1. viral contamination in foodstuffs demonstrated so far 2. verified human diseases caused by the intake of virus-contaminated foodstuff and 3. speculations on imaginable consequential damage caused by the consumption of food containing virus. This is also dealt with in the paper. In a final, critical review the importance of virus contained in food is discussed comprehensively from a scientific, legal and practical point of view.

Animals↗

[Nonspecific prophylaxis and therapy of Pseudomonas aeruginosa wound-infections with paramunization using a mouse-model (author's transl)].

The effectiveness of paramunization as a antigen nonspecific method to activate mechanisms against wound-infections due to Pseudomonas aeruginosa was studied using a model of direct infection of mice with a "mice-pathogenic" Ps. aeruginosa strain on artificially set wounds. Active paramunization by means of a biological inducer "PIND-AVI" (M-HP 438) significantly reduced the mortality rate between treated and placebo animals. The best results were obtained by parenteral prophylactic application. A four times repeated injection of PIND-AVI before the wound-infection reduced the mortality rate from 80% (placebo animals) to 26.6%. Almost equally good results were obtained by clinically useful therapeutic application of the preparation. A four times repeated treatment of the mice after wound infection lead to a decrease of mortality rates from 86.6% to 36.6%. The paramunization inducer PIND-AVI caused no side effect in any of the experiments. The mode of inducer action in Pseudomonas aeruginosa wound infections appears to be complex. Increased phagocytosis by nonspecific opsonisation, increased macrophage activity and concurrent stimulation of the lymphopoetic system could possible occur. On the other hand the nonspecific action of mediators could also play a role due to the inducer stimulated T-cells and cellular antigens of Pseudomonas aeruginosa. However both mechanisms in cooperation with specific and nonspecific humoral factors are probably interacting together. To what extent a simultaneous synthesis resp. release of endogeneous interferon plays a role is not known.

Administration, Intranasal↗

[Premunity, premunization and paraspecific effect of immunizations (author's transl)].

A considerable part of the paraspecific effect of immunization falls under the common term of a general increase in resistance. Bacterial competition, antibiosis, interference, interferon formation and lymphocyte stimulation, on the other hand, are more than an increase in resistance. It is proposed that the sum of the stimulation of all these activities including increased resistance shall be called premunization and the short-lasting nonspecific protection against a number of quite different infectious diseases produced by this in the body shall be called premunity. Experience with the paraspecific effect of immunizations, with increasing drug resistance, interferonization and lymphocyte stimulation form the basis for the development of a "premunity inducer". The efficacy of a biological inducer is described with reference to our own experiments.

Cross Reactions↗

In vitro studies on Borna virus. I. The use of cell cultures for the demonstration, titration and production of Borna virus.

Borna virus produces non-lytic infections in a wide spectrum of primary cell cultures and cell lines. The sensitivity and virus yields vary with the different cell systems. Accurate virus titrations can be performed in the RK 13 cell line by counting immunoflourescent microfoci between the 5th and 10th day after infection. Since the virus is not released from the cells and does not spread via the culture medium, the use of a semisolid overlay in unnecessary in virus titrations. The cell line most productive for Borna virus is the CV 1 line. The conditions for optimum virus production include a prolonged cultivation period of at least two weeks with regular changes of medium, and an incubation temperature of 35 degrees C. Harvest of the virus requires thorough disruption of the infected cells, preferably by ultrasonication, since Borna virus seems to be closely associated with cellular structures.

Borna disease virus↗

[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)].

The MVA virus is a lab virus ideally suited for vaccination of both man and animal which can be differentiated from the known Vaccinia strains by the use of numerous biological markers. Its reduced virulence for the chick embryo, for experimental animals and for man is a particularly characteristic feature. With the exception of chick embryo fibroblasts, the MVA virus grows in cell cultures only abortively. This applies particularly to cells of human origin in which the cytopathic effect and plaque formation are completely missing. The restriction analysis of the DNS of the MVA virus demonstrates that its genetic structure differs from that of the CVA basic virus and other orthopox viruses. In contrast to the WHO reference strain Elstree, the MVA virus has a genome shortened by about 9 per cent. The use of the MVA virus for human vaccination is particularly indicated in persons to be vaccinated for the first time and likely to entail a risk (on account of allergies etc.) because it brings about a state of revaccination without complications. The MVA virus can be administered in intracutaneous, subcutaneous or intramuscular injections. Innocuoursness and successful vaccination have been demonstrated in more than 120000 persons. While other Vaccinia strains, such as the Elstree virus, experience a drastic increase of virulence in the immunosuppressed organism (subjected to whole-body irradiation), the MVA virus cannot be activated not even in this situation.

Animals↗

Vaccination against pox diseases under immunosuppressive conditions.

Pox diseases, caused either by smallpox virus or zoonotic pox viruses or animals, continue to be of potential danger to a non-vaccinated population. Mass vaccinations will become necessary and will then also be administered to persons with immunological aberrations. The vaccines which are presently used against smallpox cause severe complications in such hosts. In contrast, the attenuated vaccinia virus strain MVA is safe even under the conditions of immunosuppression and is recommended for the production of smallpox vaccines. Because of the special epizootic situations and the numerous immunosuppressive factors present in developing countries, the use of such a safe pox vaccine there is of crucial importance.

Animals↗

Controlled field trials with oral and nasal immunization against tetanus in humans.

Under field conditions, the comparative effectiveness of oral, nasal and intramuscular vaccination of humans with tetanus toxoid was investigated. The effectiveness was tested by the determination of antitoxin titers with the L+-method. Oral booster vaccination produced only very low and irregular increases in antitoxin titer even at the highest dose of 6,000 Lf toxoid. In the most favourable case following triple oral immunization, a rise from 6.2 to 6.6 I.U. was achieved. Primary oral vaccination failed to stimulate measurable antitoxin production. After nasal booster vaccination with 1,000 Lf toxoid, a ten-fold rise in antitoxin titer was detectable. Following primary nasal vaccination, an average neutralization titer of 1 I.U. was achieved. The results of intramuscular and nasal booster vaccinations were similar although the antitoxin titers were significantly higher after primary intramuscular vaccination than after primary nasal vaccination. The average antitoxin titer amounted to 11.6 I.U. These results indicate that primary and booster vaccination against tetanus by the nasal route is a safe and effective procedure.

Administration, Intranasal↗

[Vaccinations of animals and human health (author's transl)].

Vaccination of animals may have both positive and negative effects on human health. The negative consequences largely occur with live vaccines. The protection provided by vaccination to animals is taken advantage of for human health in the most diverse ways, both directly and indirectly. Typical examples are vaccination of dogs and cats against against rabies and inoculation against diseases of cattle, horses and dogs in which reoviruses of serotypes 1, 2 and 3 are involved. An important contribution to the protection of human health is also provided by vaccination with inactivated pathogens against leptospirosis and salmonellosis, against stomatitis vesicularis and American equine encephalitis and in developing countries against brucellosis.

Animals↗

[Experimental investigations on the immunity development in irradiated mice after local and parenteral immunization with tetanus-toxoid (author's transl)].

Using the "tetanus-mouse" model the differences in immunity development between animals exposed to irradiation (300 R and 400 R) and animals not exposed to irradiation after nasal and subcutaneous vaccination was investigated. Immunization was carried out 1, 3, 6 and 10 days before and after exposure to irradiation. Efficacy of immunization was tested by challenge with 10 X LD50 tetanus-toxin and by antitoxin determination with L+-method. The degree of the immune response was dependent on 1. the irradiation dose, 2. the interval between active immunization and the ensuing or preceding irradiation, 3. the mode of vaccination (local or parenteral) and 4. the vaccination dose.

Animals↗

[A new possibility of "non-parenteral" (local) vaccination: immunization per wound (author's transl)].

Hitherto the term "non-parenteral" (local) vaccination meant all those modes of vaccination where the vaccine is applied on the skin or the mucous membranes. The most common types of local immunization are oral and nasal vaccination. Using model studies with the mouse immunization per wound was investigated as an alternative mode of vaccination. Immunization was done with tetanus-toxoid, efficiency was tested by challenge with 10 LD50 tetanus toxin. For immunization per wound only slightly higher antigen doses are necessary compared with subcutaneous immunization. A single subcutaneous vaccination with 2 Lf tetanus-toxoid and a single application per wound of 10 Lf resulted in the same efficiency index of 100. Immunization per wound has to be carried out immediately after injury. It seems to be optimal within the first 3 to 5 hours. At a later time the same efficiency index can only be achieved by use of a higher antigen doses. Immunization per wound is possible with all kinds of wound, even with burns. Size of wound and wound-supply do not influence the efficacy of wound-immunization. Immunization per wound does not disturb wound healing. The experiments reported here showed, for the first time, that immunization per wound is as effective as parenteral immunization. The most important advantage of wound-immunization is the speed and ease with which it can be administered, a fact which predestines it for vaccination in emergency cases. In practice it will be useful to combine wound-vaccination with wound-sprays.

Administration, Topical↗

[New topics in infectious medicine (author's transl)].

After the eradication and control of the old classical epidemics, the situation in the sector of infectious diseases has changed. These days 3 groups of infectious diseases have gained importance than they had in the past and thus have changed the scene: I. Infectious diseases which earlier were either not known on such a scale or completely unknown Under this group fall mainly the "infectious factor diseases" caused by so-called "opportunistic" germs, mixed infections, old and new zoonoses, iatrogenic infections, "explosion epidemics" and epidemics caused by germ mutations. II. Therapy-resistant infectious diseases Here a distinction is made between infectious diseases caused by chemotherapy-resistant germs and the diseases whose increased rate of incidence is due to the fact that the arthropod vectors became resistant to insecticides. III. Infectious diseases to which the classical Henle-Koch postulates no longer apply These are chronic diseases and persistent infections, immunopathogenic consequences of infections and viral tumours. The diseases are discussed separately with respect to the cause/effect relationship with the emphasis on the following subjects: Opportunistic problem germs, infectious factor diseases with hospitalism, mixed infections, salmonellosis and new viral zoonoses, chronic diseases, "slow viruses", immunopathogenic consequences of infections and viral tumours.

Animals↗